{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:09:52Z","timestamp":1785722992014,"version":"3.56.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1067313C"],"award-info":[{"award-number":["TCVGH-1067313C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231458","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T17:28:54Z","timestamp":1587403734000},"page":"e0231458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7304-4587","authenticated-orcid":true,"given":"Hsin-Hua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Yi","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Gotcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Chun","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"issue":"2","key":"pone.0231458.ref001","first-page":"302","article-title":"Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences","volume":"21","author":"CT Chou","year":"1994","journal-title":"The Journal of rheumatology"},{"issue":"2","key":"pone.0231458.ref002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S1807-59322011000200012","article-title":"Gender differences in ankylosing spondylitis-associated cumulative healthcare utilization: a population-based cohort study","volume":"66","author":"HH Chen","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"pone.0231458.ref003","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10067-016-3471-y","article-title":"Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan","volume":"36","author":"HH Chen","year":"2017","journal-title":"Clinical rheumatology"},{"issue":"1","key":"pone.0231458.ref004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/ard.2008.100164","article-title":"Role of contextual factors in health-related quality of life in ankylosing spondylitis","volume":"69","author":"VS Gordeev","year":"2010","journal-title":"Annals of the rheumatic diseases"},{"key":"pone.0231458.ref005","first-page":"S108","article-title":"Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis","volume":"27","author":"U Kiltz","year":"2009","journal-title":"Clinical and experimental rheumatology"},{"issue":"4","key":"pone.0231458.ref006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/art.11197","article-title":"Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis","volume":"49","author":"R Ariza-Ariza","year":"2003","journal-title":"Arthritis and rheumatism"},{"issue":"4","key":"pone.0231458.ref007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1529-0131(199908)12:4<247::AID-ART3>3.0.CO;2-H","article-title":"Health-related quality of life in ankylosing spondylitis: a survey of 175 patients","volume":"12","author":"MM Ward","year":"1999","journal-title":"Arthritis Care Res"},{"issue":"1","key":"pone.0231458.ref008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"C Stolwijk","year":"2015","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"pone.0231458.ref009","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"D van der Heijde","year":"2017","journal-title":"Annals of the rheumatic diseases"},{"key":"pone.0231458.ref010","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1046\/j.1523-1755.2000.07407.x","article-title":"Epidemiology of end-stage renal disease: International comparison of renal replacement therapy","volume":"57","author":"FP Schena","year":"2000","journal-title":"Kidney international"},{"issue":"12","key":"pone.0231458.ref011","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1093\/ndt\/gfn406","article-title":"Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance","volume":"23","author":"WC Yang","year":"2008","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"key":"pone.0231458.ref012","unstructured":"Basthesda MD. U.S. Renal Data System USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2007."},{"issue":"1","key":"pone.0231458.ref013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00683881","article-title":"Increased incidence of recurrent hematuria in ankylosing spondylitis: a possible association with IgA nephropathy","volume":"4","author":"BA Wall","year":"1984","journal-title":"Rheumatology international"},{"issue":"5","key":"pone.0231458.ref014","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/ard.48.5.435","article-title":"IgA nephropathy associated with ankylosing spondylitis: occurrence in women as well as in men","volume":"48","author":"KN Lai","year":"1989","journal-title":"Annals of the rheumatic diseases"},{"issue":"35","key":"pone.0231458.ref015","first-page":"1655","article-title":"Association of ankylosing spondylitis and IgA nephropathy. A new example of IgA disease?","volume":"21","author":"C Beauvais","year":"1992","journal-title":"Presse Med"},{"issue":"4","key":"pone.0231458.ref016","first-page":"220","article-title":"Renal abnormalities in ankylosing spondylitis","volume":"8","author":"B Samia","year":"2012","journal-title":"Nephrologie & therapeutique"},{"issue":"3","key":"pone.0231458.ref017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan's new national health insurance program: genesis and experience so far","volume":"22","author":"TM Cheng","year":"2003","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"pone.0231458.ref018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"S van der Linden","year":"1984","journal-title":"Arthritis and rheumatism"},{"key":"pone.0231458.ref019","unstructured":"WHO Collaborating Center for Drugs Statistics Methodology. WHO Collaborating Center for Drugs Statistics. ATC Index with DDDs 2017 Oslo, Norway, WHO, 2017."},{"issue":"4","key":"pone.0231458.ref020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2188\/jea.JE20080099","article-title":"End-stage renal disease in Taiwan: a case-control study","volume":"19","author":"SY Tsai","year":"2009","journal-title":"Journal of epidemiology \/ Japan Epidemiological Association"},{"issue":"21","key":"pone.0231458.ref021","first-page":"3085","article-title":"Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects","volume":"268","author":"WG Walker","year":"1992","journal-title":"The MRFIT Research Group. JAMA: the journal of the American Medical Association"},{"key":"pone.0231458.ref022","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15-year end-stage renal disease in hypertensive patients","volume":"25","author":"HM Perry","year":"1995","journal-title":"Hypertension"},{"issue":"4","key":"pone.0231458.ref023","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00004872-199715040-00016","article-title":"History of hypertension in patients treated for end-stage renal disease","volume":"15","author":"TV Perneger","year":"1997","journal-title":"Journal of hypertension"},{"issue":"3","key":"pone.0231458.ref024","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2007.11.009","article-title":"Prevalence and factors associated with CKD: a population study from Beijing. American journal of kidney diseases: the official journal of the","volume":"51","author":"L Zhang","year":"2008","journal-title":"National Kidney Foundation"},{"issue":"38","key":"pone.0231458.ref025","doi-asserted-by":"crossref","first-page":"e1362","DOI":"10.1097\/MD.0000000000001362","article-title":"Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study","volume":"94","author":"YK Chang","year":"2015","journal-title":"Medicine"},{"issue":"6","key":"pone.0231458.ref026","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ard.2009.116178","article-title":"Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study","volume":"69","author":"JH Kang","year":"2010","journal-title":"Annals of the rheumatic diseases"},{"issue":"Suppl 1","key":"pone.0231458.ref027","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/rheumatology\/35.suppl_1.56","article-title":"An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment","volume":"35","author":"PJ Bevis","year":"1996","journal-title":"British journal of rheumatology"},{"issue":"1","key":"pone.0231458.ref028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1997.tb00030.x","article-title":"Meloxicam pharmacokinetics in renal impairment","volume":"43","author":"JM Boulton-Jones","year":"1997","journal-title":"British journal of clinical pharmacology"},{"issue":"6","key":"pone.0231458.ref029","first-page":"635","article-title":"Mechanism and effect of cyclooxygenase-2 inhibitor meloxicam on the protection of diabetic nephropathy in rats","volume":"29","author":"ZC Liu","year":"2004","journal-title":"Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences"},{"issue":"3","key":"pone.0231458.ref030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000020665","article-title":"Preferential COX-2 inhibitor, meloxicam, compromises renal perfusion in euvolemic and hypovolemic rats","volume":"8","author":"R Birck","year":"2000","journal-title":"Experimental nephrology"},{"issue":"18","key":"pone.0231458.ref031","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/archinte.1997.00440390111014","article-title":"A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study","volume":"157","author":"GS Boyer","year":"1997","journal-title":"Has the classic case misled us? Archives of internal medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T17:29:23Z","timestamp":1587403763000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231458"}},"subtitle":[],"editor":[{"given":"Nicholas M.","family":"Selby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}